CV Sciences, Inc.
http://cvsciences.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From CV Sciences, Inc.
CV Sciences Makes Move For Increased Softgel Capacity, Captek Launches Gummy Production
CV Sciences closes purchase of Elevated Softgels, a manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry. Captek Softgel starts gummy supplement production at a 60,000-square foot facility.
Asia Deal Watch: SciClone Obtains Commercial Rights In China To Menarini Breast Cancer Drug
Plus deals involving Fujimoto/Egetis, Chugai/Cheplapharm, Celest/Senti, Shionogi/Apnimed, Jiangsu Hengrui/Merck KGaA, Jiangsu Hengrui/Elevar, Sun/Zydus, C4U/Healiva, Shanghai Henlius/Intas, Ono/Turbine, EpimAB/Almirall and Alar/Indivior.
Swiss R&D Innovation: A Tale Of Two Firms Developing Cell Therapies For Wounds
While perhaps best known for historical achievements in immuno-oncology and CNS disorders, the Swiss biotech sector is slowly cultivating a new area of expertise in dermatology. Scrip spoke with two firms applying cell therapy technologies to the challenging area of chronic and acute wounds.
Deals Update (05/2007)
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Company Information
- Industry
- Distributors
-
Medical Devices
- Laser
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
-
- Canabine
- CannaVest
- CanX Inc
- Foreclosure Solutions, Inc
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice